Last week was an exciting one for anyone with shares of Arvinas (NASDAQ: ARVN) or Biogen (NASDAQ: BIIB) in their portfolio. Both soared more than 30% during the week ended Oct. 25, and investors who didn't have these rockets in their portfolio might feel they're missing out.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,